Litts Drug Eruption & Reaction Database - Presented by CRC Press

... an essential tool for dermatologists and other specialists Spencer D. Hawkins, The Dermatologist


Log in
In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Continue
Menu
Login
  • Home
  • About About
    • About the Database
    • About the Book
    • Related Products
    • About Dr Litt
    • About Dr Shear
  • Alerts
  • Litt’s App
  • Contact Us
  • Help
  • Subscribe Subscribe
    • Individual Subscription
    • Institutional Subscription

Drugs belonging to  restart save

class – Angiogenesis inhibitor / antiangiogenic agent – 16 items found

  • show all
  • 0–9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Aflibercept

Axitinib

Bevacizumab

Cabozantinib

Lenvatinib

Nintedanib

Pazopanib

Pegaptanib

Ponatinib

Ramucirumab

Ranibizumab

Regorafenib

Sorafenib

Sunitinib

Vandetanib

Zotarolimus


Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Angiogenesis inhibitor / antiangiogenic agent'

Please login to view adverse reactions.

Rash

    • (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]

Hypertension

    • (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]

Appetite decreased

    • (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]

Lymphopenia (lymphocytopenia) / lymphocytes decreased

    • (2024): Cao RB+, Medicine (Baltimore) 103(31), e38679 (≥ grade 3) [REVIEW]

Adverse effects / adverse reactions

    • (2023): Simion L+, Diagnostics (Basel) 13(6), 1040 [REVIEW]
    • (2022): Zhang C+, J Ovarian Res 15(1), 99 [REVIEW]

Saved Searches Watched Drugs
Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Back to top
  • Help
  • Terms & Conditions
  • Privacy
  • Disclaimer
  • Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.